China Healthcare Stocks
Biopharmaceutical and medical technology firms in this cohort leverage the rapid modernization of the Chinese regulatory landscape and a massive, aging domestic patient base to commercialize novel therapies and digital health platforms.
As of Oct 23, 2026, China Healthcare has 12 US-listed companies worth $8.1B combined. The median member moved +1.4% over the past week; POM led at +85.2% and BDMD trailed at -21.3%.
Companies in China Healthcare
- ZLAB – Zai Lab Ltd, $2.7B
- HCM – HUTCHMED DRC, $2.5B
- AAPG – Ascentage Pharma Group International, $1.4B
- GYRE – Gyre Therapeutics Inc., $717M
- WDH – Waterdrop Inc ADR, $366M
- ADAG – Adagene Inc, $165M
- BNR – Burning Rock Biotech Ltd, $158M
- BDMD – Baird Medical Investment Holdings Limited, $24.1M
- CCM – Concord Medical Services Holdings, $16.2M
- ZCMD – Zhongchao Inc, $8.2M
- POM – POMDOCTOR LIMITED American Depositary Shares, $6.9M
- WOK – WORK Medical Technology Group LTD Ordinary Shares, $6.7M